Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis
NCT00677092
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Nephrogenic Systemic Fibrosis
Interventions
DRUG:
Imatinib mesylate
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]